Skip to main content

Table 1 Baseline characteristics of study participants in the three feeding groups in the intention-to-treat population

From: Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial

Characteristic

Experimental group

(n = 144)

Control group

(n = 145)

Breastfed group

(n = 60)

Age at enrollment, days

6.8 (3.98)

6.7 (3.80)

4.8 (3.83)

Sex, % male

47.9%

46.9%

41.7%

Days breastfed since birth

3.3 (2.95)

4.4 (3.53)

4.8 (3.83)

Days fed formula since birth

6.3 (3.78)

6.3 (3.91)

N/A

Race, % Caucasian

97.9%

95.2%

90.0%

Gestational age, weeks

39.3 (1.17)

39.1 (1.03)

39.3 (1.02)

Delivery method, % Caesarean

33.3%

33.8%

20.0%

Birth weight, kg

3.3 (0.44)

3.4 (0.42)

3.4 (0.43)

Birth length, cm

49.8 (1.71)

50.0 (2.02)

50.2 (2.04)

Birth head circumference, cm

34.4 (1.42)

34.3 (1.37)

34.6 (1.28)

Mother’s age, years

31.0 (5.42)

30.9 (5.73)

30.9 (4.96)

Mother’s educational attainment, % completed college

20.8%

20.7%

40.0%

  1. Data are presented as mean values (standard deviations) or percentages